Discover how our AI-powered platform has transformed clinical trials across therapeutic areas by accelerating enrollment, improving retention, and optimizing site performance. Leading with oncology excellence, proven across all specialties.
A phase III trial for a novel therapy faced slow recruitment due to stringent biomarker criteria. Our AI-driven platform identified and matched eligible patients 75% faster by analyzing genomic data and clinical records, enabling the trial to meet enrollment goals ahead of schedule. This oncology case study demonstrates our platform's capability for any complex biomarker-driven trial.
Faster enrollment
Sites activated
Patient eligibility accuracy
A complex clinical trial struggled with high dropout rates. Our predictive analytics and personalized engagement tools increased patient retention by 92%, ensuring robust data collection and trial success through automated follow-ups and real-time support. Originally proven in oncology, these retention strategies now serve all therapeutic areas.
Retention rate
Reduced dropout risk
Patient satisfaction
A multi-site clinical trial faced delays in site activation. Our platform's real-time monitoring and analytics reduced activation time by 60%, streamlining operations and improving site performance across 20+ locations. These site optimization capabilities, refined through oncology trials, benefit all therapeutic areas.
Reduced activation time
Sites optimized
Operational efficiency
Learn how our oncology-proven platform can accelerate your clinical trials across all therapeutic areas with precision and efficiency.
